Cargando…
MicroRNA-21 as an Early Marker of Nephropathy in Patients with Type 1 Diabetes
INTRODUCTION: Diabetic nephropathy (DN) is the most common cause of chronic kidney disease worldwide. A major challenge is to identify early diabetic nephropathy. microRNAs (miRNAs) are short noncoding RNA sequences and regulate a wide range of biological processes as cell differentiation, prolifera...
Autores principales: | Fouad, Mohamed, Salem, Ibrahim, Elhefnawy, Khaled, Raafat, Nermin, Faisal, Amal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977383/ https://www.ncbi.nlm.nih.gov/pubmed/32015595 http://dx.doi.org/10.4103/ijn.IJN_80_19 |
Ejemplares similares
-
MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy
por: Liu, Shuijiao, et al.
Publicado: (2022) -
MicroRNA-21 Silencing in Diabetic Nephropathy: Insights on Therapeutic Strategies
por: Dhas, Yogita, et al.
Publicado: (2023) -
Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Elsheikh, Mohamed, et al.
Publicado: (2019) -
Kidney microRNA-21 Expression and Kidney Function in IgA Nephropathy
por: Szeto, Cheuk-Chun, et al.
Publicado: (2020) -
The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy
por: Szostak, Joanna, et al.
Publicado: (2023)